Active · per the CBE, 31 October 2026

VIAPHINE

BE1003769460

Rechtspersoon Limited partnership 1 establishment

VIAPHINE is a pharmacy in Gent. Limited partnership, started on 21 December 2023, 1 establishment.

Gustaaf Callierlaan 223, 9000 Gent

Active for

2 year, 10 months

nothing found

No annual accounts yet

This company hasn't filed annual accounts with the National Bank yet. As soon as one arrives, the analysis appears here.

What happened to VIAPHINE?

What happened at VIAPHINE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

  • New establishment in Gent. KBO
  • Start of the company according to the CBE. KBO

Establishments

Establishment units

Physical locations of this company

Registered office

Gustaaf Callierlaan 223

9000 Gent

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number
1003.769.460
VAT number
BE 1003.769.460
Registered office
Gustaaf Callierlaan 223, 9000 Gent
Names & denominations
VIAPHINE
Enterprise type
Rechtspersoon
Legal form
Limited partnership
Legal situation
Normale toestand
Start date
21 December 2023
Peppol
Active · Active since 26 Mar 2025
Activities · NACE

Detailhandel in farmaceutische producten

Overige zakelijke dienstverlening, neg

Frequently asked questions

What does VIAPHINE do?
VIAPHINE is a pharmacy in Gent. Limited partnership, started on 21 December 2023, 1 establishment.
What is the address of VIAPHINE?
The registered office of VIAPHINE is located at Gustaaf Callierlaan 223, 9000 Gent.
Is VIAPHINE still active?
Yes. According to the CBE (31 October 2026) VIAPHINE is active, legal situation “Normale toestand”, started on 21 December 2023.
Is VIAPHINE registered on Peppol?
Yes, VIAPHINE is registered on the Peppol network with ID 0208:1003769460.
What is the enterprise number of VIAPHINE?
The enterprise number of VIAPHINE is BE1003769460.
When was VIAPHINE founded?
VIAPHINE was founded on 21 December 2023.